Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.61 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.58 |
| ▸ | MEN1 | O00255 | 2/20 | 0.54 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.54 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.54 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.53 |
| ▸ | LMNA | P02545 | 1/20 | 0.53 |
| ▸ | PGR | P06401 | 1/20 | 0.53 |
| ▸ | MAPT | P10636 | 2/20 | 0.52 |
| ▸ | UGT1A1 | P22309 | 1/20 | 0.52 |
| ▸ | SQLE | Q14534 | 6/20 | 0.50 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.48 |
| ▸ | ATM | Q13315 | 1/20 | 0.48 |
| ▸ | POLB | P06746 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6905709 | 1.00 | ALDH1A1 (0.61) | ALDH1A1KMT2AMEN1CYP3A4ALOX15 | |
| SCHEMBL6905665 | 0.96 | KMT2A (0.67) | ALDH1A1KMT2AMEN1CYP3A4ALOX15 | |
| SCHEMBL6905662 | 0.96 | KMT2A (0.67) | ALDH1A1KMT2AMEN1CYP3A4ALOX15 | |
| SCHEMBL6906368 | 0.82 | NR1I2 (0.77) | ALDH1A1KMT2AMEN1CYP3A4ALOX15 | |
| SCHEMBL28575170 | 0.80 | NR1I2 (0.76) | ALDH1A1KMT2AMEN1CYP3A4ALOX15 | |
| SCHEMBL6905552 | 0.78 | NR1I2 (0.56) | ALDH1A1KMT2AMEN1CYP3A4ALOX15 | |
| SCHEMBL25396940 | 0.78 | ALDH1A1 (0.64) | ALDH1A1KMT2AMEN1CYP3A4ALOX15 | |
| SCHEMBL10711405 | 0.78 | ALDH1A1 (0.64) | ALDH1A1KMT2AMEN1CYP3A4ALOX15 | |
| SCHEMBL1618949 | 0.78 | ALDH1A1 (0.64) | ALDH1A1KMT2AMEN1CYP3A4ALOX15 | |
| SCHEMBL1618947 | 0.78 | ALDH1A1 (0.64) | ALDH1A1KMT2AMEN1CYP3A4ALOX15 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 26 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118058281-B | Application of DMNT in preventing and controlling liriomyza sativae | 浙江大学海南研究院 | 2024-07-12 | — | — | CN | claimed |
| US-4125735-A | Synthesis of esters of acetylenic alcohols | SCM CORPORATION (US) | 1978-11-14 | — | — | US | claimed |
| US-4115466-A | ACETYLENIC HYDROCARBONS FROM ACETYLENIC CARBINOLS, ISOMERIZATION | SCM CORPORATION (US) | 1978-09-19 | — | — | US | claimed |
| CN-118058281-B | Application of DMNT in preventing and controlling liriomyza sativae | 浙江大学海南研究院 | 2024-07-12 | — | — | CN | disclosed |
| CN-118058281-A | Application of DMNT in preventing and controlling liriomyza sativae | 浙江大学海南研究院 | 2024-05-24 | — | — | CN | disclosed |
| US-6703527-B2 | REACTING ALLYL ALCOHOL COMPOUND SUCH AS 2E,6E-3,7,11-TRIMETHYL-2,6,10-DODECATRIEN-1-OL WITH HYDRIDE ACCEPTOR SUCH AS 2-NITROBENZALDEHYDE IN THE PRESENCE OF AN ALUMINIUM ALKOXIDE AS AN OPPENAUER OXIDATION CATALYST | NIKKEN CHEMICALS CO., LTD. (JP) | 2004-03-09 | — | — | US | disclosed |
| EP-0837062-B1 | Preparation of cyclocarbonates | HOFFMANN LA ROCHE (CH) | 2003-12-03 | — | — | EP | disclosed |
| US-20020198411-A1 | Method for oxidation of allyl alcohol | NIKKEN CHEMICALS CO., LTD. (JP) | 2002-12-26 | — | — | US | disclosed |
| US-6441177-B1 | Tertiary amines | HOFFMANN-LA ROCHE INC. | 2002-08-27 | — | — | US | disclosed |
| EP-0778264-B1 | Tertiary amines having antimycotic and cholesterol lowering activity | HOFFMANN LA ROCHE (CH) | 2001-07-11 | — | — | EP | disclosed |
| US-6034275-A | FUGICIDES; ATICHOLESTEROL AGENTS | HOFFMANN-LA ROCHE INC. (US) | 2000-03-07 | — | — | US | disclosed |
| EP-0311955-B1 | BICYCLIC PEROXIDE | F. HOFFMANN-LA ROCHE AG (CH) | 1993-04-21 | — | — | EP | disclosed |
| EP-0525516-A2 | Derivatives of beta substituted cinnomic acid | BASF Aktiengesellschaft (DE) | 1993-02-03 | — | — | EP | disclosed |
| US-5134240-A | Malaria therapy | HOFFMANN-LAROCHE, INC. (US) | 1992-07-28 | — | — | US | disclosed |
| US-4977184-A | Bicyclic peroxides compositions for and treatment of malaria therewith | HOFFMANN-LA ROCHE INC. (US) | 1990-12-11 | — | — | US | disclosed |
| EP-0311955-A2 | Bicyclic peroxide | F. HOFFMANN-LA ROCHE AG (CH) | 1989-04-19 | — | — | EP | disclosed |
| US-4788344-A | Process for the preparation of polyene ethers | RHONE-POULENC SANTE (FR) | 1988-11-29 | — | — | US | disclosed |
| US-4760193-A | Process for the preparation of polyene aldehydes | RHONE-POULENC SANTE (FR) | 1988-07-26 | — | — | US | disclosed |
| US-4055575-A | HYDROGENATION, SAPONIFICATION | SCM CORPORATION (US) | 1977-10-25 | — | — | US | disclosed |
| US-4039591-A | 1-ACETOXY-4-CHLORO-3-METHYLBUT-2-ENE | SCM CORPORATION (US) | 1977-08-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020198411-A1 | Method for oxidation of allyl alcohol | ADH1A, ADH1C, ADH5 | ALDH1A1 11/4885KMT2A 750/4885MEN1 3696/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.